COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,400 Articles (22,816 medRxiv, 8,584 bioRxiv)

Most recent first Previous |  Page 214: Articles 2131-2140  | Next

Overweight and Obesity as Predictors of Post-acute Sequelae of SARS-Cov-2 Infection: Findings from the RECOVER Initiative
ZHOU, T., Zhang, B., Zhang, D., Wu, Q., Becich, M., Blecker, S. B., Chen, J., Chilukuri, N., Chrischilles, E. A., Chu, H., Corsino, L., Geary, C. R., Hornig, M., Kim, S., Liebovitz, D. M., Lorman, V., Lu, Y., Luo, C., Morizono, H., Mosa, A. S. M., Pajor, N. M., Rao, S., Razzaghi, H., Suresh, S., Tedla, Y. G., Vance Utset, L., Wang, Y., Williams, D. A., Gage Witvliet, M., Mangarelli, C., Jhaveri, R., Forrest, C., Chen, Y.
10.1101/2024.06.12.24308868 — Posted: 2024-06-14
Comparing lagged impacts of mobility changes and environmental factors on COVID-19 waves in rural and urban India: a Bayesian spatiotemporal modelling study
Cleary, E., Atuhaire, F., Sorcihetta, A., Ruktanonchai, N., Ruktanonchai, C., Cunningham, A., Pasqui, M., Schiavina, M., Melchiorri, M., Bondarenko, M., Shepherd, H. E. R., Padmas, S. S., Wesolowski, A., Cummings, D. A. T., Tatem, A. J., Lai, S.
10.1101/2024.06.12.24308871 — Posted: 2024-06-14
COVID-19 advocacy bias in the BMJ: meta-research evaluation
Kepp, K. P., Cristea, I. A., Muka, T., Ioannidis, J.
10.1101/2024.06.12.24308823 — Posted: 2024-06-14
AIVE: accurate predictions of SARS-CoV-2 infectivity from comprehensive analysis
Park, J., Choi, W., Seong, D. Y., Jeong, S., Lee, J. Y., Park, H. J., Chung, D. S., Yi, K., Kim, U., Yoon, G.-Y., Kim, H., Kim, T., Ko, S., Min, E. J., Cho, H.-S., Cho, N.-H., Hong, D.
10.1101/2024.06.14.598983 — Posted: 2024-06-14
Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology
Wickenhagen, A., Flagg, M., Port, J., Yinda, C. K., Goldin, K., Gallogly, S., Schulz, J. E., Lutterman, T., Williamson, B., Kaiser, F., Mukesh, R., Van Tol, S., Smith, B., van Doremalen, N., Russell, C., de Wit, E., Munster, V.
10.1101/2024.06.13.598902 — Posted: 2024-06-14
Optimization of Soluble Expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD Fusion Proteins as Candidates for COVID-19 Intranasal Vaccines
Tarigan, S., Sumarningsih, S., Setyawati, D. R., Tarigan, R., Sekarmila, G., Apas, A., Putri, R.
10.1101/2024.06.13.598952 — Posted: 2024-06-14
Profiling endogenous airway proteases and antiproteases and measuring proteolytic activation of Influenza HA using in vitro and ex vivo human airway surface liquid samples
Brocke, S. A., Reidel, B., Ehre, C., Rebuli, M. E., Robinette, C., Schichlein, K. D., Brooks, C. A., Jaspers, I.
10.1101/2024.06.14.599031 — Posted: 2024-06-14
Did institutional racism contribute to adverse COVID-19 clinical outcomes in ethnic minority healthcare staff? Systematic review
Adewole, T., Lalli, K., Peters, H., Price, C., Lumb, B., Gal, M., Cooper, A.
10.1101/2024.06.11.24308764 — Posted: 2024-06-13
Evaluation of a flow cytometry-based surrogate assay (FlowSA) for the detection of SARS-CoV-2 in clinical samples
Upasani, V., Knoester, M., Pantano, D., Gard, L., Smit, J., van der Gun, I., Tami, A., Rodenhuis-Zybert, I. A.
10.1101/2024.06.12.24308675 — Posted: 2024-06-13
Innovative COVID-19 Point-of-Care Diagnostics Suitable for Tuberculosis Diagnosis: A Scoping Review
Holtgrewe, L. M., Jain, S., Dekova, R., Broger, T., Isaacs, C., Nahid, P., Cattamanchi, A., Denkinger, C. M., Yerlikaya, S.
10.1101/2024.06.13.24308880 — Posted: 2024-06-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).